Programmed death-ligand 1 (PD-L1) expression in Grade Group 1 (GG1) prostate carcinoma biopsies has not been established as a marker of pathological upgrading at radical prostatectomy (RP). This two-center retrospective case–control study included 172 men with GG1 carcinoma in the biopsy closest to RP: all 86 patients...
L. Pepe, V. Zuccalà, Ida Rizzuto et al.· International Journal of Mol...· 0 citations
Glioblastoma, IDH-wildtype (GBM) is the most common and aggressive primary brain tumor in adults, with a median overall survival of 15–18 months. New therapeutic targets are needed to improve patients’ prognosis. Due to their powerful regulatory capabilities, miRNAs could be possible candidate targets. MiR-126 is consi...
G. Castellani, M. Buccarelli, A. Affinito et al.· Molecular Therapy: Nucleic A...· 0 citations
Conventional techniques, including DNA- and RNA-based next-generation sequencing, PCR-based companion diagnostic assays, fluorescence in situ hybridization, and immunohistochemistry are critically discussed together with emerging liquid biopsy strategies for longitudinal disease monitoring and resistance assessment.
Gabriele Ricciardi, Mariagiovanna Ballato, P. Tralongo et al.· Clinical Genitourinary Cance...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.